Tuberculosis kills 1.3 million people each year, making it the deadliest infectious disease in the world, write KJ Seung and.

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able to outpace the damage?

Pune: BJ Medical College and Sassoon General Hospital will now undertake ‘targeted' genome sequencing of 50 tuberculosis ...

Resistance to synthetic antibiotics poses a critical global health challenge. Various European honeybee and other natural ...

"We need to design services around people, not the disease," rightly said Dr Nittaya Phanuphak. Unless point-of-care health technologies are deployed for those who are most-in-need in a person-centred ...

DRESS emphasize personalized care, topical therapies, and selective reintroduction protocols, offering hope for better ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Cancer statistics are equally grim. The Kenya National Cancer Registry estimates 42,000 new cancer cases and 27,000 deaths ...

Beyond bringing back diseases like measles and TB, defunding NIH will cost the United States its leading role in global ...

S ince they were first deployed almost 100 years ago, antibiotics – originally discovered in soil – have saved millions of ...

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...

THE United States Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences' lenacapavir, a drug to be injected twice annually, for preventing HIV infection in adults and adolescents at ...